Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 09/30/19
Due: 09/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Genomics Used to Improve DEpression Decisions | NCT02109939 | Assurex Health Inc. | user2@example.com | None | 2014-04-30 | 2017-07-31 | 2018-07-31 | - | - | 2025-07-14 |
| Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm | NCT01632267 | Assurex Health Inc. | user2@example.com | None | 2011-01-31 | 2011-09-30 | 2012-09-30 | - | - | 2025-07-14 |
| Pharmacogenetic-Directed Treatment for Major Depression | NCT01261364 | Assurex Health Inc. | user2@example.com | None | 2009-09-30 | 2011-09-30 | 2012-09-30 | - | - | 2025-07-14 |
| Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder | NCT02466477 | Assurex Health Inc. | user2@example.com | None | 2015-06-30 | 2019-09-30 | 2020-09-30 | - | - | 2025-07-14 |